It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Purpose
Prognostic prediction is crucial to guide individual treatment for locoregionally advanced nasopharyngeal carcinoma (LA-NPC) patients. Recently, multi-task deep learning was explored for joint prognostic prediction and tumor segmentation in various cancers, resulting in promising performance. This study aims to evaluate the clinical value of multi-task deep learning for prognostic prediction in LA-NPC patients.
Methods
A total of 886 LA-NPC patients acquired from two medical centers were enrolled including clinical data, [18F]FDG PET/CT images, and follow-up of progression-free survival (PFS). We adopted a deep multi-task survival model (DeepMTS) to jointly perform prognostic prediction (DeepMTS-Score) and tumor segmentation from FDG-PET/CT images. The DeepMTS-derived segmentation masks were leveraged to extract handcrafted radiomics features, which were also used for prognostic prediction (AutoRadio-Score). Finally, we developed a multi-task deep learning-based radiomic (MTDLR) nomogram by integrating DeepMTS-Score, AutoRadio-Score, and clinical data. Harrell's concordance indices (C-index) and time-independent receiver operating characteristic (ROC) analysis were used to evaluate the discriminative ability of the proposed MTDLR nomogram. For patient stratification, the PFS rates of high- and low-risk patients were calculated using Kaplan–Meier method and compared with the observed PFS probability.
Results
Our MTDLR nomogram achieved C-index of 0.818 (95% confidence interval (CI): 0.785–0.851), 0.752 (95% CI: 0.638–0.865), and 0.717 (95% CI: 0.641–0.793) and area under curve (AUC) of 0.859 (95% CI: 0.822–0.895), 0.769 (95% CI: 0.642–0.896), and 0.730 (95% CI: 0.634–0.826) in the training, internal validation, and external validation cohorts, which showed a statistically significant improvement over conventional radiomic nomograms. Our nomogram also divided patients into significantly different high- and low-risk groups.
Conclusion
Our study demonstrated that MTDLR nomogram can perform reliable and accurate prognostic prediction in LA-NPC patients, and also enabled better patient stratification, which could facilitate personalized treatment planning.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Fudan University Shanghai Cancer Center, Department of Nuclear Medicine, Shanghai, People’s Republic of China (GRID:grid.452404.3) (ISNI:0000 0004 1808 0942); Shanghai Medical College, Fudan University, Department of Oncology, Shanghai, People’s Republic of China (GRID:grid.11841.3d) (ISNI:0000 0004 0619 8943); Fudan University, Center for Biomedical Imaging, Shanghai, People’s Republic of China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, People’s Republic of China (GRID:grid.8547.e); Fudan University, Key Laboratory of Nuclear Physics and Ion-Beam Application (MOE), Shanghai, People’s Republic of China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)
2 the University of Sydney, School of Computer Science, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
3 National Center for Translational Medicine, Shanghai Jiao Tong University, Institute of Translational Medicine, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)